Back to news

Why Zimmer Biomet (ZBH) Stock Is Down Today

Investivoq PriceTracker

Zimmer Biomet Holdings (ZBH) is down 4.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be continued investor concern around Zimmer Biomet’s recently disclosed restructuring actions, including a proposed major workforce reduction in Switzerland, combined with leadership changes tied to its commercial transformation. There does not appear to be a separate major positive company update offsetting those concerns today, so the selloff may reflect pressure from investors reassessing execution risk.

Details:

  • Zimmer Biomet disclosed a restructuring proposal in Switzerland that could eliminate up to 580 positions at its Winterthur site as part of efforts to simplify its manufacturing footprint and supply chain.
  • Local officials in Winterthur said they are pushing back on the potential cuts, highlighting concern about the production site and broader regional economic impact.
  • Earlier this month, the company also announced leadership changes in the Americas and global business organization, including the departure of a senior executive, as it works to accelerate a commercial transformation.
  • In that same announcement, the company reiterated its full-year 2026 outlook, which suggests today’s decline is more likely tied to restructuring and execution worries than to a formal guidance cut.
  • Sources:

    SEC, MedTech Dive, City of Winterthur

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $ZBH Insider Trading Activity

    $ZBH insiders have traded $ZBH stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

    Here’s a breakdown of recent trading of $ZBH stock by insiders over the last 6 months:

    • KEVIN R THORNAL (Grp Pres-Global Business) sold 5,691 shares for an estimated $528,978
    • SANG YI (Group President, Asia Pacific) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $413,216.
    • CHAD F PHIPPS (See remarks below.) sold 3,000 shares for an estimated $295,050

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    Investivoq Alerts
    Receive ZBH Data Alerts
    Get market-moving data, filings, and signals for ZBH in real time.
    Sign Up

    $ZBH Hedge Fund Activity

    We have seen 396 institutional investors add shares of $ZBH stock to their portfolio, and 484 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • FRANKLIN RESOURCES INC removed 5,103,543 shares (-93.6%) from their portfolio in Q2 2026, for an estimated $439,364,016
    • PRICE T ROWE ASSOCIATES INC /MD/ removed 3,202,555 shares (-40.0%) from their portfolio in Q2 2026, for an estimated $275,707,959
    • CAPITAL INTERNATIONAL INVESTORS added 3,064,392 shares (+33.6%) to their portfolio in Q2 2026, for an estimated $263,813,507
    • UBS GROUP AG added 1,385,250 shares (+100.9%) to their portfolio in Q2 2026, for an estimated $119,256,172
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,377,103 shares (+inf%) to their portfolio in Q2 2026, for an estimated $118,554,797
    • VICTORY CAPITAL MANAGEMENT INC removed 1,325,043 shares (-53.5%) from their portfolio in Q2 2026, for an estimated $114,072,951
    • AMERICAN CENTURY COMPANIES INC removed 1,218,743 shares (-30.8%) from their portfolio in Q2 2026, for an estimated $104,921,584

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $ZBH Government Contracts

    We have seen $10,731,122 of award payments to $ZBH over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    • BASE PLUS TWO YEAR SERVICE AGREEMENT. ROSA KNEE PREMIUM AND LITE WARRANTY: $197,500
    • THE PURPOSE OF THIS DELIVERY ORDER IS TO PAY THE UNPAID INVOICES FOR FY24 AND FY25. THIS DELIVERY ORDER IS ...: $195,000
    • 4571007457!ROSA 6 MONTH USAGE: $114,000
    • PREVENTIVE MAINTENANCE AND REPAIR SERVICE FOR ROSA ONE BRAIN SYSTEM: $98,000

    To track government contracts to publicy traded companies, check out Investivoq's government contracts dashboard. You can access data on government contracts through the Investivoq API government contracts endpoint.

    $ZBH Congressional Stock Trading

    Members of Congress have traded $ZBH stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $ZBH stock by members of Congress over the last 6 months:

    • SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.

    To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.

    $ZBH Price Targets

    Multiple analysts have issued price targets for $ZBH recently. We have seen 10 analysts offer price targets for $ZBH in the last 6 months, with a median target of $95.0.

    Here are some recent targets:

    • Vik Chopra from BMO Capital set a target price of $95.0 on 07/09/2026
    • Vijay Kumar from Evercore ISI Group set a target price of $110.0 on 07/06/2026
    • Joanne Wuensch from Citigroup set a target price of $93.0 on 05/28/2026
    • Richard Newitter from Truist Securities set a target price of $92.0 on 04/29/2026
    • Rick Wise from Stifel set a target price of $105.0 on 04/29/2026
    • David Turkaly from Citizens set a target price of $105.0 on 04/29/2026
    • Larry Biegelsen from Wells Fargo set a target price of $90.0 on 04/29/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.